:: Against-the-rule astigmatism associated
with pseudophakic pseudoaccommodation
IN PATIENTS with mild to moderate against-the-rule astigmatism who are undergoing cataract surgery with implantation of a monofocal posterior chamber IOL, preserving the astigmatism and aiming for a slightly myopic postoperative refraction appears to increase their likelihood of benefiting from pseudophakic pseudoaccommodation, according to the results of a study conducted at the University of North Carolina School of Medicine, Chapel Hill. - Download pdf here
IN PATIENTS with mild to moderate against-the-rule astigmatism who are undergoing cataract surgery with implantation of a monofocal posterior chamber IOL, preserving the astigmatism and aiming for a slightly myopic postoperative refraction appears to increase their likelihood of benefiting from pseudophakic pseudoaccommodation, according to the results of a study conducted at the University of North Carolina School of Medicine, Chapel Hill. - Download pdf here
:: Anti-VEGF compounds augur well for
diabetic retinopathy treatment
HAVING generated much interest in the treatment of age-related macular degeneration, anti-angiogenic drugs such as pegaptanib sodium (Macugen, Pfizer Inc.), ranibizumab (Lucentis, Genentech) and bevacizumab (Avastin, Genentech) are also showing considerable promise in both slowing and relieving the effects of diabetic retinopathy - Download pdf here
HAVING generated much interest in the treatment of age-related macular degeneration, anti-angiogenic drugs such as pegaptanib sodium (Macugen, Pfizer Inc.), ranibizumab (Lucentis, Genentech) and bevacizumab (Avastin, Genentech) are also showing considerable promise in both slowing and relieving the effects of diabetic retinopathy - Download pdf here
:: Application of nerve growth factors
enhances corneal healing
THE application of nerve growth factors to the corneal surface may enhance the regeneration of epithelial tissue in eyes with ocular surface disease and may improve the success of corneal grafts, said Friedrich E Kruse MD, University of Erlangen, Erlangen, Germany. - Download pdf here
THE application of nerve growth factors to the corneal surface may enhance the regeneration of epithelial tissue in eyes with ocular surface disease and may improve the success of corneal grafts, said Friedrich E Kruse MD, University of Erlangen, Erlangen, Germany. - Download pdf here
:: Bio-Ophthalmology
HIV protease inhibitors may find use in treatment of retinal degeneration - Download pdf here
HIV protease inhibitors may find use in treatment of retinal degeneration - Download pdf here
e-TIMES newsletter
E-Times is a new bi-monthly newsletter with the latest breaking news from the ESCRS and the world of ophthalmology.
E-Times is a new bi-monthly newsletter with the latest breaking news from the ESCRS and the world of ophthalmology.
Media Guide 2009
Results from our readership survey plus information about adverting in EuroTimes
Results from our readership survey plus information about adverting in EuroTimes
Podcasts
Eye Contact features interviews with key opinion leaders in the world of ophthalmology
Eye Contact features interviews with key opinion leaders in the world of ophthalmology
Monday, 13 October 2008
www.eurotimes.org
EuroTimes Breaking News
German survey shows trend toward customised LASIK treatments in refractive surgery
Date Posted 13/10/2008 MORE HERE...
Date Posted 13/10/2008 MORE HERE...